Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 26Active not recruiting 12Recruiting 11Unknown 3Terminated 3Withdrawn 2Suspended 1Enrolling by invitation 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 3Breast 3Thoracic 2Other hematologic neoplasm 2Gastrointestinal 2Other 1Genitourinary 1Dermatologic 1

Conditions

Breast Neoplasms 2Motor Activity 1Arthralgia 1Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Trastuzumab 87Cyclophosphamide 67Capecitabine 67Paclitaxel 64Docetaxel 58Fulvestrant 52Letrozole 50Carboplatin 42pembrolizumab 41Lapatinib 38Doxorubicin 36Anastrozole 32Vinorelbine 31Bevacizumab 31exemestane 28Tamoxifen 25Gemcitabine 25Albumin-Bound Paclitaxel 25Radiotherapy 21Taxes 19atezolizumab 18pertuzumab 17Everolimus 17130-nm albumin-bound paclitaxel 17Epirubicin 16palbociclib 15Magnetic Resonance Spectroscopy 15eribulin 14Ado-Trastuzumab Emtansine 14Goserelin 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Educational Status × Breast × Clear all
NCT05452681 2026-05-07

Piloting Y-AMBIENT: A Quality of Life Intervention for Young African American Breast Cancer Survivors

University of Alabama at Birmingham

Phase NA Terminated
27 enrolled
Breast

Breast Neoplasms

NCT05243056 2026-05-06

A Quality of Life Intervention for Young African American Breast Cancer Survivors in Treatment

University of Alabama at Birmingham

Phase NA Terminated
37 enrolled
Breast

Anatomic Stage I Breast Cancer AJCC v8

NCT01351844 2017-08-30

CEASE

George Washington University

Phase NA Terminated
12 enrolled
Breast

Breast Neoplasms, Motor Activity, Arthralgia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡